Financial Snapshot

This section of the Fusion Pharmaceuticals InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Fusion Pharmaceuticals assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQFUSN
Beta(1.17)
Shares Outstanding44.8M
Average Volume (10 days)69.3K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.99)
Sales (TTM)--
Book Value (MRQ)$4.48
Cash Flow (TTM)($1.87)
Cash (MRQ)$3.90

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy9
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Chau Q. Khuong
Director
42,093
Acquire
Nov 11, 2022
Steven Gannon
Director
44,400
Buy
Aug 11, 2022
John Valliant
Director, Chief Executive Officer
(4,511)
Sell
Apr 27, 2022
John Valliant
Director, Chief Executive Officer
(2,147)
Sell
Apr 26, 2022
John Valliant
Director, Chief Executive Officer
(2,036)
Sell
Apr 25, 2022

Recent SEC Filings

SC 13D/A
May 16, 2023
Quarterly Financials
May 11, 2023
Company Events
May 11, 2023
Proxy Statement
Apr 27, 2023
DEFA14A
Apr 27, 2023
NEVER MISS AN UPDATE